Results 61 to 70 of about 156,534 (140)

Knowledge landscape of macrophage research in liver fibrosis: a bibliometric review of the literature from WoSCC

open access: yesFrontiers in Pharmacology
Recent insights into the immune response in fibrosis have provided valuable perspectives for the treatment of liver fibrosis. Macrophages, as the most abundant immune cells in the liver, are key drivers of liver fibrosis. They are extensively involved in
Yanbo Li   +4 more
doaj   +1 more source

Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines

open access: yesMolecular Therapy: Nucleic Acids
Intranasal vaccination aims to elicit mucosal immunity in the respiratory tract to better protect against respiratory infections (e.g., SARS-CoV-2 and influenza). Most vaccines, including recent COVID-19 mRNA lipid nanoparticles (LNPs), are optimized for
Mai N. Vu   +7 more
doaj   +1 more source

Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation

open access: yesFrontiers in Antibiotics
IntroductionOptimizing vancomycin dosing in neonates is a critical yet complex goal. Traditional trough concentration-based dosing strategies correlate poorly with therapeutic efficacy and often fail to account for the significant renal function ...
Sílvia M. Illamola   +17 more
doaj   +1 more source

Patterns of treatment and outcomes of patients with metastatic HER2-low breast cancer treated with CDK4/6 inhibitors and hormone therapy

open access: yesDrugs in Context
Background: The 2018 American Society of Clinical Oncology/College of American Pathologists guidelines classified immunohistochemistry (IHC) 1+ or 2+, FISH-negative breast cancer as HER2-low. To date, only a few studies have investigated the role of HER2-
Federico Sottotetti   +11 more
doaj   +1 more source

20(S)-protopanaxadiol inhibits proliferation and induces apoptosis of acute myeloid leukemia cells via targeting Bcl-XL and MCL-1

open access: yesFrontiers in Pharmacology
Currently, intensive chemotherapy with cytarabine and anthracycline (the “7 + 3” regimen) and hypomethylating agents remains the standard treatment for patients with acute myeloid leukemia (AML).
Meng Xu   +11 more
doaj   +1 more source

Curcumin: a potential anti-photoaging agent

open access: yesFrontiers in Pharmacology
Turmeric, also referred to as Curcuma longa, is a commonly used spice, recognized for its demonstrated effects in reducing inflammation, combating microbes, providing antioxidant benefits, slowing the aging process, and exhibiting anticancer potential ...
Yuhong Nie, Yiming Li
doaj   +1 more source

Case Report: Linezolid-associated toxic optic neuropathy in patients with pulmonary tuberculosis: case series and mini review

open access: yesFrontiers in Pharmacology
Linezolid is a useful second-line medication for the treatment of tuberculosis that is resistant to multiple drugs. However, long-term therapy can cause side effects, such as optic neuropathy.
Hee Jin Yun   +8 more
doaj   +1 more source

Efficacy and safety of baihe gujin decoction as an adjunct to chemotherapy in pulmonary tuberculosis: A systematic review and meta-analysis

open access: yesFrontiers in Pharmacology
BackgroundPulmonary tuberculosis (PTB), an ancient affliction, continues to present significant challenges in modern medicine. Baihe Gujin Decoction, a traditional Chinese botanical drug remedy, has been widely utilized in clinical practice for ...
Yilu Zhao   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy